Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term mometasone furoate nasal spray in children with perennial allergic rhinitis
2014-004922-16Phase 3
- Sponsor
- Merck & Co.
- Start
- Feb 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of mometasone in perennial rhinitis, sponsored by Merck & Co. Primary endpoint: Safety.
02
Drugs
mometasone
03
Conditions
perennial rhinitis
Beyond the preview
Go deeper on 2014-004922-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004922-16.